Home / Pathology / Stratipath Breast
Stratipath AB (Stockholm, SE)Stratipath Breast
Swedish AI that estimates the risk of disease progression on standard H&E slides of breast cancer, as a faster and cheaper complement to gene expression tests.
Shared spot4of 13 professional tools with a GDPR profileOur summary of what the provider itself publishes about your data: whether the data is stored in the EU (2 points), whether there is a certification or GDPR guarantee (1), and whether the provider is based in the NL or the EU (1). 3 or 4 points is Strong, 2 Good, 1 Limited, 0 Unknown. How we measure in pathology
GDPR: Limited
- Provider based in the EU
Priceon request
Free trialNot foundNot found on the provider's site when checked on 4 October 2026
Based inStockholm, SEEU
ModelNot publicproprietary deep-learning model (spin-off from Karolinska Institutet); CE-IVD. Delivered as SaaS. Hosting and ISO 27001 are not publicly stated, so ask and conclude a data processing agreement.
Last checked: 4 October 2026 · How we check
Is this your tool? Fill in missing detailsWhat it does
Breast cancer risk profile on H&E sections
Classification into high and low risk
Deep learning on routine pathology images
CE-IVD marked for EU and UK
Faster and cheaper than a gene expression test
SaaS, connects with digital pathology
Validated on large external datasetsComparable in pathology
Proscia Concentriqon request
Aiforiaon request
Tribun Health CaloPixon request
Aiosynon request
Mindpeakon request
Sectra Digital Pathologyon requestUnderlying model
GDPR check for pathology Proprietary deep-learning model (spin-off from Karolinska Institutet); CE-IVD. Delivered as SaaS. Hosting and ISO 27001 are not publicly disclosed, so ask and sign a data processing agreement. Many tools build on a large model from, for example, OpenAI or Anthropic. If in doubt, ask for the data processing agreement: it sets out where your data goes.
Questions about Stratipath Breast
- Which AI model does Stratipath Breast use?
- The maker of Stratipath Breast does not publicly disclose which AI model sits underneath. Own deep-learning model (spin-off from the Karolinska Institutet); CE-IVD. Delivered as SaaS. Hosting and ISO 27001 are not publicly listed, so ask the provider and conclude a data processing agreement.
- How much does Stratipath Breast cost?
- on request. Check the current price on the provider's website; rates change often.
- Who is Stratipath Breast for?
- Stratipath Breast focuses on pathology. It suits work such as digitising and managing tissue sections in an image management system (scanners, IMS, archive), detecting and grading cancer on H&E sections (e.g. Gleason score, mitosis counting, tumour size), and counting and quantifying biomarkers in IHC staining (HER2, ER/PR, Ki-67, PD-L1).
- What should I watch out for with AI in pathology?
- You process special category personal data (health) and sometimes data for genetic research. Software for diagnostic use is an in vitro diagnostic medical device: check whether the algorithm is CE-marked under the IVDR for your exact application and tissue type. Many apps are 'research use only'. Choose providers with ISO 27001 and ISO 13485, a data processing agreement and clear data location (EU hosting or on-premise). Also ask whether your slides are used to train models. Under the EU AI Act, medical AI falling under the IVDR is classed as high-risk. Validate every algorithm locally on your own scanner and stains before using it in routine practice.
Every Friday: what changed in AI for pathology
New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.